Cubans develop synthetic vaccines

Cuban researchers have produced the first synthetic vaccine against pneumonia and meningitis, press reports said on Saturday.

    Discovery may lead to the future of disease prevention

    Vicente Verez, head of the University of Havana's Antigen Research Center, told the Cuban press agency AIN the vaccine would be presented to a biotechnology congress in Havana from 23-28 November.

    He said the vaccine was designed to be administered to infants in three doses - at two, four and six months - with a booster at 18 months.

    Clinical studies done in Camaguay in central Cuba showed that more than 99% of babies vaccinated developed antibodies against the pneumonia and meningitis viruses as well as other diseases, he said.

    Synthetically produced vaccines offer many advantages over conventional vaccines, including enhanced purity and effectiveness. They also have a longer shelf life and can be mass produced, potentially at a lower cost.

    SOURCE: AFP


    YOU MIGHT ALSO LIKE

    Survivor stories from Super Typhoon Haiyan

    Survivor stories from Super Typhoon Haiyan

    The Philippines’ Typhoon Haiyan was the strongest storm ever to make landfall. Five years on, we revisit this story.

    How Moscow lost Riyadh in 1938

    How Moscow lost Riyadh in 1938

    Russian-Saudi relations could be very different today, if Stalin hadn't killed the Soviet ambassador to Saudi Arabia.

    We Are Still Here: A Story from Native Alaska

    We Are Still Here: A Story from Native Alaska

    From Qatar to Alaska, a personal journey exploring what it means to belong when your culture is endangered.